These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 16817249)
21. The role of treatment to increase HDL-cholesterol and decrease triglyceride concentrations in prevention of coronary heart disease in Type 2 diabetes. Wild S; Byrne CD Diabet Med; 2004 Sep; 21 Suppl 4():8-11. PubMed ID: 15315518 [No Abstract] [Full Text] [Related]
22. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
23. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease. Ravindran R; Krishnan LK Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614 [TBL] [Abstract][Full Text] [Related]
24. Triglycerides and coronary artery disease. Sum CF; Tan CE; Wang KW Singapore Med J; 1992 Oct; 33(5):443-5. PubMed ID: 1455264 [No Abstract] [Full Text] [Related]
25. The relationship between serum LDL-cholesterol, HDL-cholesterol and systolic blood pressure in patients with type 2 diabetes. Nasri H; Yazdani M Kardiol Pol; 2006 Dec; 64(12):1364-8; discussion 1369-71. PubMed ID: 17206540 [TBL] [Abstract][Full Text] [Related]
26. Reverse cholestrol transport substantially influences the individual risk of coronary heart disease in hypercholesterolaemic patients. Poledne R; Rosolová H Eur Heart J; 2001 Mar; 22(6):442-3. PubMed ID: 11237535 [No Abstract] [Full Text] [Related]
27. [Comparison of 2 electrophoretic procedures for quantifying lipoprotein cholesterol]. Kessler B; Aufenanger J; Kattermann R Klin Wochenschr; 1990; 68 Suppl 22():110-1. PubMed ID: 2087065 [No Abstract] [Full Text] [Related]
28. Patterns of lipid changes among type 2 diabetes patients in Sudan. Elnasri HA; Ahmed AM East Mediterr Health J; 2008; 14(2):314-24. PubMed ID: 18561723 [TBL] [Abstract][Full Text] [Related]
29. [Measurement of apolipoproteins is better than routinely measured traditional lipids]. Kallner A; Estonius M Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202 [No Abstract] [Full Text] [Related]
30. Lifestyle approaches and dietary strategies to lower LDL-cholesterol and triglycerides and raise HDL-cholesterol. Katcher HI; Hill AM; Lanford JL; Yoo JS; Kris-Etherton PM Endocrinol Metab Clin North Am; 2009 Mar; 38(1):45-78. PubMed ID: 19217512 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of atorvastatin for achieving cholesterol targets after LDL-cholesterol based dose selection in patients with type 2 diabetes. Ferrer-García JC; Sanchez-Ballester E; Albalat-Galera R; Berzosa-Sanchez M; Herrera-Ballester A J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):183-8. PubMed ID: 18635754 [TBL] [Abstract][Full Text] [Related]
32. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612 [TBL] [Abstract][Full Text] [Related]
33. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey. Bruckert E; Baccara-Dinet M; Eschwege E Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463 [TBL] [Abstract][Full Text] [Related]